China Still Main Source of Fentanyl in US as Chinese Traffickers Evolve Tactics: Report

A Drug Enforcement Administration (DEA) chemist pours 2,500 packs of confirmed fentanyl onto a counter for testing at the DEA Northeast Regional Laboratory in New York on Oct. 8, 2019. Don Emmert/AFP via Getty Images

Despite the Chinese regime banning fentanyl and its analogs in 2019, China remains the primary source of illicit fentanyl and fentanyl-related substances being trafficked into the United States, according to a new report by a U.S. congressional advisory body.

Chinese traffickers have found sophisticated ways to circumvent these regulations, a U.S.–China Economic and Security Review Commission (USCC) report states. This includes shifting their business from manufacturing finished fentanyl to exporting precursors to Mexican cartels, who then produce the drug and traffick it across the border.

Those evasion efforts have been enabled by the Chinese regime’s “weak supervision and regulation” of its chemical industry, the report states.

The findings come as U.S. agencies have continued to grapple in recent years with the country’s devastating opioid crisis, fueled by a surge in the use of fentanyl, a synthetic opioid 50 times more potent than heroin, and its variants.

The United States saw a record number of overdose deaths from synthetic opioids in 2020, at more than 56,000—a rise of 20,000 from 2019, according to provisional data by the National Center for Health Statistics.

Chinese Traffickers Embrace Mexican Cartels

Since Beijing’s ban on fentanyl in 2019, there has been a decline in the amount of finished fentanyl shipped directly from China—typically by mail—into the country, the report states, but illicit fentanyl has remained widely available in the United States.

To evade authorities, Chinese traffickers have pivoted their operations to focus mainly on producing and shipping chemical precursors to Mexico, the USCC report states, citing the U.S. Drug Enforcement Administration (DEA). This also means Chinese traffickers have increased their cooperation with Mexican cartels, particularly with the country’s two most powerful crime syndicates, the Sinaloa cartel and the Jalisco New Generation cartel.

The cartels control “pill mills” in Mexican cities, which manufacture finished fentanyl from the China-sourced precursors. They then smuggle the drug into the United States.

“The growing involvement of Mexican cartels and advanced money laundering schemes have exacerbated the problem,” the report reads.

Meanwhile, Chinese money launderers have been working to aid Mexican drug cartels in their criminal operations, the USCC report states. U.S. prosecutors have charged several Chinese nationals in recent years for laundering money for drug cartels. In one case, Gan Xianbing, a Chinese national, was sentenced to 14 years over a money-laundering operation for Latin American cartels that involved tens of millions in drug money.

Limited US–China Cooperation

While U.S. and Chinese authorities have worked together to dismantle some illegal fentanyl networks, cooperation between the two sides “remains limited on the ground,” according to the report.

“There remain significant gaps in U.S.-China antidrug cooperation, especially in enforcement and criminal prosecution.”

Chinese regulators continue to delay requests to access potential sites where precursors are made, according to the USCC. The delay often takes days, “allowing any illegal operation to vacate or clean up the premises.”

During the investigation of the Gan case, the DEA didn’t receive any support from its Chinese counterpart, despite multiple informal requests for assistance, the report states.

It also cites retired DEA agent Jeffrey Higgins, who told the USCC in 2018 that he felt that “China is merely seeking to create the appearance of cooperating with U.S. officials, while not enacting any reforms.”

In response to the report’s findings, the Chinese Foreign Ministry told Reuters the accusations were unreasonable and unacceptable, saying that the regime has strictly controlled all narcotics, psychotropic drugs, and chemical precursors.

In 2019, a Chinese narcotics official admitted that cooperation between China and the United States on investigating and prosecuting fentanyl was “extremely limited.”

The DEA and U.S. State Department didn’t respond to requests for comment by press time.